Our Story
NSGO-CTU was founded in 2006.
We are a non-profit organization with the main objective to manage and support clinical research in gynaecologic cancer.
While the organization’s Danish name is, “Nordisk Selskab for Gynækologisk Onkologi’s Kliniske Forskningsfond,” it is commonly referred to as NSGO-CTU and is headquartered at Rigshospitalet in Copenhagen, Denmark.
As a recognized international group and collaborative partner, our daily focus is on developing, initiating, and conducting quality clinical trials within the field of gynaecological oncology to contribute to future advances for patients.
NSGO-CTU is overseen by a Medical Director who is accountable to the NSGO-CTU Foundation Committee, also known as the NSGO-CTU Foundation Board. The Medical Director is appointed for three-year terms and may be reappointed indefinitely in the best interest of the Foundation and NSGO-CTU.
Dr. Kristine Madsen (DK) is appointed Medical Director to manage the Clinical Trial Unit.
NSGO-CTU collectively consists of:
- The Medical Director
- The NSGO-CTU Foundation Committee
- The staff of the NSGO-CTU Office
- The NSGO-CTU Scientific Committee
The Mission
NSGO-CTU are strong collaborators among professionals in the field of gynaecological cancer. The Clinical Trial Unit conducts educational meetings for colleagues and industry partners.
We organize the Biannual NSGO-CTU Investigator Meeting in Copenhagen and provide updates on the latest developments in cancer research.
NSGO-CTU is affiliated with ENGOT and maintains partnerships with GOG to advance clinical research in the field of gynaecological oncology. In addition to conducting clinical trials in the Nordic countries, our society aims to provide education and training to future Principal Investigators (PIs) and sub-investigators.
Our activities also involve mentoring other groups & organizations and promoting collaboration and camaraderie among experts and organizations worldwide engaged in the field of gynaecological oncology.
The Purpose
Clinical trials are an integral component of medical research that assesses the safety, efficacy, and effectiveness of new drugs, medical devices, or treatment modalities. These trials typically involve a complex and multi-faceted process that involves many different stakeholders, including clinicians, researchers, patients, regulatory bodies, and funding agencies. Given the complexity of clinical trials, it is crucial to have effective project management in place to ensure that the research progresses in a timely and efficient manner and that all stakeholders are engaged and informed throughout the process.
As a project management team for clinical trials research, our primary responsibility is to oversee and coordinate all aspects of the research project from start to finish. We work closely with clinical trial investigators to design and develop the trial protocol, define inclusion and exclusion criteria, and identify the appropriate patient population for the study. We also collaborate with regulatory bodies to ensure that the study meets all ethical and regulatory requirements.
One of our critical roles is to oversee the recruitment of patients and ensure that the study is conducted in compliance with Good Clinical Practice (GCP) guidelines. We develop a detailed project plan that outlines the timelines, milestones, and deliverables for the study and ensure that the research team adheres to the plan. We monitor the progress of the study, identify any issues or concerns that arise, and take corrective action as needed to keep the project on track.
Another essential function of our project management team is to facilitate communication and collaboration among all stakeholders. We work closely with study sponsors and funding agencies to ensure that they are updated on the project’s progress and that the study remains aligned with their goals and objectives. We also communicate regularly with the clinical trial investigators and research team to ensure that they are aware of any updates or changes in the study design, protocol, or timelines.
Our responsibility is to ensure that the research project is conducted efficiently, ethically, and in compliance with regulatory guidelines & ensure effective communication and collaboration throughout the project.
NSGO-CTU Office
NSGO-CTU Leadership
NSGO-CTU Team
Mia Sejer Donner
Contract Manager
(On Maternity leave)
Karen Stampe Petersson
Project Manager
(On Maternity leave)
NSGO-CTU Address:
Nordic Society of Gynaecological Oncology – Clinical Trial Unit
Department of Cancer Treatment, 9431
Rigshospitalet
Copenhagen University Hospital
Blegdamsvej 9
DK-2100 Copenhagen, Denmark
Call us:
Phone: +45 35 45 33 11
Phone hours:
Monday – Thursday: 09.00 – 15.00
Friday: 09.00 – 14.00
NSGO-CTU Bylaws
The Nordic Society of Gynaecological Oncology Clinical Trial Unit (NSGO-CTU) operates under a structured set of bylaws that govern its operations. By maintaining clear and up-to-date bylaws, NSGO-CTU strengthens its governance, supports collaborative decision-making, and reinforces its commitment to excellence in gynaecological oncology across the Nordic region.
You can find the newest version of the NSGO-CTU Bylaws through the button bellow:
Foundation Governance
Foundation Committee
The NSGO-CTU Foundation Committee (Board members) is named for a two-year period.
- Trine Jakobi Nøttrup (Chair)
- Charlotte Aaquist Haslund
- Line Bjørge
- Hanna Dahlstrand
- Annika Auranen
Scientific Committee
The Scientific Committee of NSGO-CTU (SC) consists of Investigator representatives from the top recruiting sites in the Nordic and Baltic countries, as well as the NSGO-CTU Foundation President and President elect. Prior NSGO presidents, and NSGO members are all invited to join the meetings.
The SC meets 8-10 times a year for Scientific Committee Meetings (SCM), where new trial proposals and trial updates are presented, reviewed, and discussed jointly. The NSGO-CTU SCM’s are arranged by the NSGO-CTU office and are led by NSGO-CTU Medical Director.
New trials within gynaeoncology are presented during the SCM, which incl. NSGO-CTU Sponsored trials, Pharma sponsored trials, and clinical trials sponsored by collaborating ENGOT groups. Following initial study presentation, the SC will evaluate and discuss the interest of NSGO-CTU to join new trials, incl. review any identified challenges regarding study design, competing trials, financial aspects, and feasibility aspects of NSGO-CTU sites for recruitment.
To be a Primary Investigator for NSGO-CTU trials, it is mandatory to be an active NSGO-member.
The SCM also include scientific presentations and updates from relevant annual conferences within gynaeoncology (e.g., ESMO, ESGO, ASCO), as well as broad discussions regarding e.g., international collaborations, translational research, and educational initiatives.
The members of the Scientific Committee are reviewed annually to accommodate for changes in recruitment status the prior year.
- Charlotte Aaquist Haslund
- Nicoline Raaschou-Jensen
- Trine Lembrecht Jørgensen
- Henrik Roed
- Josefin Fernebro
- Susanne Malander
- Gabriel Lindahl
- Anthoula Koliadi
- Jone Trovik
- Kristina Lindemann
- Elisabeth Berge Nilsen
- Maarit Anttila
- Synnöve Staff
- Sakari Hietanen
- Birute Brasiüiené
- Kristina Ojamaa
Translational Research Group
Mission Statement:
To move translational science toward greater health impact for gynecological cancers.
Objectives:
To promote and formalize translational research work within NSGO.
The main activities are:
- To participate in writing of protocols for NSGO-CTU lead clinical trials to secure design, sample size and sample collection for proper translational research.
- To establish standards operation procedures for:
- Sample collections and biobanking.
- Publication rules.
- Data ownership.
- External collaborations.
Members:
- Line Bjørge (Chair)
- Hanna Dahlstrand
- Anniina Färkkilä
- Estrid Høgdall